// App-Quantinova.ai

e21070 : Association of immune-inflammation index with outcome of high-risk acral melanoma patients treated with adjuvant high-dose interferon.

Researchers

Presenter

  • Jiayi Yu

Principal Investigators

  • Si Ming Li

  • Yan Kong

  • Lu Si

  • Xinan Sheng

  • Zhihong Chi

  • Chuanliang Cui

  • Jun Guo

Medical Centers

  • Peking University Cancer Hospital & Institute, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • Cluster of Differentiation 25

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Lactate dehydrogenase

  • Regulatory T cells

Drug/Treatment

  • Interferon

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved